Whether to build or buy prior authorization software comes down to how specific your needs are and how much control and integration you require. Buy when a packaged product covers your workflow and you want speed. Build when your workflow, integrations or product strategy are differentiated enough that off-the-shelf software cannot fit. For many organisations the best answer is a third path: buy or use core components, and build the custom automation and integration layer on top.
This decision matters more now because of CMS-0057-F, which requires impacted US payers to run a FHIR Prior Authorization API by January 1, 2027, and because AI-assisted prior-auth automation is advancing fast. Getting the build-versus-buy call right affects cost, speed to compliance and how well the system fits your reality. This guide gives you a clear comparison and a decision framework.
Should you build or buy prior authorization software?
Buy when your prior authorization process is fairly standard and a packaged product covers it, because buying is faster and needs less in-house engineering. Build when your workflow, payer mix, integrations or product ambitions are distinctive enough that a generic product forces you to compromise.
The honest answer for most organisations is that it is not purely one or the other. Packaged products handle common cases well but rarely fit every payer rule, EHR quirk and internal workflow. So the real question is usually how much you buy, how much you build, and where the line sits. That is what the rest of this guide helps you decide.
What does "buy" give you, and what are its limits?
Buying gives you speed and a proven product, so you avoid building core functionality from scratch. A packaged electronic prior authorization tool can be live quickly, is maintained by the vendor, and spreads cost across many customers.
The limits show up at the edges. Off-the-shelf products reflect the vendor's view of the workflow, not yours, so they may not match every payer rule, EHR integration or internal process. Customisation can be limited, you depend on the vendor's roadmap, and deep integration into your systems is not always possible. Buying is excellent for standard needs and frustrating when your needs are specific.
What does "build" give you, and what are its costs?
Building gives you control and fit: software shaped exactly to your workflow, payer mix, integrations and product strategy, with no vendor lock-in. For organisations whose prior authorization process is a differentiator, or who are building a product around it, that fit is worth a lot.
The cost is time, engineering and ownership. Building takes longer than buying, requires healthcare-and-standards-fluent engineers, and means you own maintenance and compliance updates. It is the right investment when the fit and control genuinely matter, and the wrong one when a packaged product would have done the job.
Build vs buy: a side-by-side comparison
Here is the trade-off at a glance. Read it against how standard your needs are, not in the abstract.
| Dimension | Buy | Build |
|---|---|---|
| Speed to launch | Fast | Slower |
| Fit to your workflow | Generic | Exact |
| Integration depth | Limited by the product | As deep as you need |
| Control and roadmap | Vendor-led | Yours |
| Upfront cost | Lower | Higher |
| Long-term cost | Ongoing licences | Ownership and maintenance |
| Lock-in | Possible | None |
| Best when | Needs are standard | Needs are differentiated |
Neither column is the winner in the abstract. The right choice depends on how standard your needs are and how much control and integration you require.
The third option: build on top of what you buy
The most pragmatic path is often a hybrid: use packaged components or a base platform for the commodity parts, and build the custom automation, integration and intelligence layer on top. This gives you speed where the work is standard and fit where it is differentiated.
In prior authorization specifically, this often means building the FHIR-based APIs, AI-assisted documentation extraction, payer-rule handling and EHR-embedded workflows that make the difference, while not rebuilding commodity plumbing from scratch. The AI in these systems is AI-assisted and human-reviewed; it prepares and predicts, and people make the decisions. This layered approach is frequently the best balance of cost, speed and fit.
Build versus buy is rarely binary. For many organisations the sharpest answer is to buy the commodity parts and build the custom automation and integration layer on top.